Compare Stocks: HIMS, DGX, LH, and GH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$235.76 +0.9%	$209.75	$171.18 ▼ $240.13	$25.80B	0.56	1.13 million shs	674,201 shs
GH Guardant Health	$163.18 +2.1%	$145.75	$43.66 ▼ $176.58	$21.44B	1.6	2.20 million shs	2.40 million shs
HIMS Hims & Hers Health	$31.65 -1.6%	$31.67	$13.74 ▼ $65.30	$7.44B	2.4	14.63 million shs	8.36 million shs
LH Labcorp	$314.30 +0.6%	$277.86	$244.52 ▼ $316.11	$25.61B	0.87	813,768 shs	502,482 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+0.69%	+0.32%	+10.45%	+23.54%	+36.01%
GH Guardant Health	+2.12%	+13.14%	-3.34%	+76.87%	+253.43%
HIMS Hims & Hers Health	-1.36%	+26.74%	-17.46%	+23.24%	-42.94%
LH Labcorp	+0.51%	+2.35%	+10.51%	+22.02%	+19.33%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$235.76 +0.9%	$209.75	$171.18 ▼ $240.13	$25.80B	0.56	1.13 million shs	674,201 shs
GH Guardant Health	$163.18 +2.1%	$145.75	$43.66 ▼ $176.58	$21.44B	1.6	2.20 million shs	2.40 million shs
HIMS Hims & Hers Health	$31.65 -1.6%	$31.67	$13.74 ▼ $65.30	$7.44B	2.4	14.63 million shs	8.36 million shs
LH Labcorp	$314.30 +0.6%	$277.86	$244.52 ▼ $316.11	$25.61B	0.87	813,768 shs	502,482 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+0.69%	+0.32%	+10.45%	+23.54%	+36.01%
GH Guardant Health	+2.12%	+13.14%	-3.34%	+76.87%	+253.43%
HIMS Hims & Hers Health	-1.36%	+26.74%	-17.46%	+23.24%	-42.94%
LH Labcorp	+0.51%	+2.35%	+10.51%	+22.02%	+19.33%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.46	Hold	$235.31	-0.19% Downside
GH Guardant Health	2.96	Moderate Buy	$183.78	12.63% Upside
HIMS Hims & Hers Health	2.19	Hold	$31.43	-0.67% Downside
LH Labcorp	2.75	Moderate Buy	$326.82	3.98% Upside

Current Analyst Ratings Breakdown

Latest HIMS, DGX, LH, and GH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/4/2026	GH Guardant Health	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$170.00 ➝ $195.00
8/4/2026	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$135.00 ➝ $193.00
8/4/2026	GH Guardant Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$175.00 ➝ $185.00
8/4/2026	LH Labcorp	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$300.00 ➝ $309.00
8/3/2026	LH Labcorp	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$330.00 ➝ $360.00
7/31/2026	LH Labcorp	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$308.00 ➝ $338.00
7/31/2026	GH Guardant Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$185.00 ➝ $200.00
7/31/2026	GH Guardant Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$210.00
7/31/2026	LH Labcorp	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$306.00
7/31/2026	GH Guardant Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$200.00 ➝ $210.00
7/31/2026	GH Guardant Health	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$130.00 ➝ $180.00

(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.56B	2.25	$15.31 per share	15.40	$70.84 per share	3.33
GH Guardant Health	$982.02M	22.30	N/A	N/A	($1.66) per share	-98.30
HIMS Hims & Hers Health	$2.35B	3.12	$0.82 per share	38.43	$2.38 per share	13.30
LH Labcorp	$13.95B	1.85	$24.98 per share	12.58	$104.96 per share	2.99

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$9.42	25.03	19.73	2.15	9.18%	16.01%	7.27%	10/20/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	N/A
HIMS Hims & Hers Health	$128.37M	-$0.09	N/A	60.86	90.51	-0.56%	6.10%	1.52%	8/10/2026 (Estimated)
LH Labcorp	$876.50M	$12.09	26.00	16.03	1.80	6.99%	16.74%	7.81%	N/A

Latest HIMS, DGX, LH, and GH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0490	N/A	N/A	N/A	$698.90 million	N/A
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion
5/11/2026	Q1 2026	HIMS Hims & Hers Health	$0.04	-$0.40	-$0.44	-$0.40	$616.84 million	$608.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.46%	+7.34%	36.52%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.92%	N/A	23.82%	N/A

Latest HIMS, DGX, LH, and GH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/9/2026	LH Labcorp	quarterly	$0.72	1.04%	8/28/2026	8/28/2026	9/11/2026
5/19/2026	DGX Quest Diagnostics	quarterly	$0.86	1.65%	7/8/2026	7/8/2026	7/22/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.72	1.59	1.46
GH Guardant Health	N/A	4.03	3.71
HIMS Hims & Hers Health	2.18	1.69	1.56
LH Labcorp	0.69	1.80	1.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
HIMS Hims & Hers Health	63.52%
LH Labcorp	95.94%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
HIMS Hims & Hers Health	11.76%
LH Labcorp	0.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
HIMS Hims & Hers Health	2,442	231.46 million	204.24 million	Optionable
LH Labcorp	71,000	82.00 million	81.31 million	Optionable

HIMS, DGX, LH, and GH Headlines

Recent News About These Companies

Bank of America Corp DE Cuts Stake in Labcorp Holdings Inc. $LH

August 5 at 3:12 AM | marketbeat.com

JPMorgan Chase & Co. Raises Labcorp (NYSE:LH) Price Target to $360.00

August 5 at 1:48 AM | americanbankingnews.com

Labcorp (NYSE:LH) Price Target Raised to $309.00

August 4 at 10:59 AM | marketbeat.com

Here's Why Labcorp Holdings (LH) is a Strong Value Stock

August 4 at 10:41 AM | zacks.com

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

August 4 at 7:00 AM | prnewswire.com

Labcorp Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation

August 3 at 7:03 PM | seekingalpha.com

Labcorp (NYSE:LH) Price Target Raised to $360.00 at JPMorgan Chase & Co.

August 3 at 11:53 AM | marketbeat.com

Pacer Advisors Inc. Trims Stock Position in Labcorp Holdings Inc. $LH

August 3 at 6:15 AM | marketbeat.com

Labcorp Holdings Inc. $LH Shares Sold by The Manufacturers Life Insurance Company

August 3 at 5:12 AM | marketbeat.com

Labcorp (NYSE:LH) Price Target Raised to $350.00

August 3 at 3:00 AM | americanbankingnews.com

Truist Financial Sticks to Their Buy Rating for Labcorp Holdings (LH)

August 2, 2026 | theglobeandmail.com

UBS Remains a Buy on Labcorp Holdings (LH)

August 2, 2026 | theglobeandmail.com

Amundi Buys 34,351 Shares of Labcorp Holdings Inc. $LH

August 2, 2026 | marketbeat.com

Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing

August 1, 2026 | finance.yahoo.com

Quantinno Capital Management LP Has $25.76 Million Stake in Labcorp Holdings Inc. $LH

August 1, 2026 | marketbeat.com

Glenmede Trust Co. NA Cuts Stake in Labcorp Holdings Inc. $LH

August 1, 2026 | marketbeat.com

LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase

July 31, 2026 | finance.yahoo.com

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Cytokinetics (CYTK)

July 31, 2026 | theglobeandmail.com

Truist Financial Boosts Labcorp (NYSE:LH) Price Target to $350.00

July 31, 2026 | marketbeat.com

Labcorp Q2 Earnings Call Highlights

July 31, 2026 | marketbeat.com

Labcorp (LH) Q2 2026 Earnings Call Transcript

July 30, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, DGX, LH, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

$235.76 +2.04 (+0.87%)

Closing price 08/5/2026 03:59 PM Eastern

Extended Trading

$236.45 +0.70 (+0.30%)

As of 08/5/2026 07:56 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$163.18 +3.39 (+2.12%)

Closing price 08/5/2026 04:00 PM Eastern

Extended Trading

$162.50 -0.68 (-0.42%)

As of 08/5/2026 07:59 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health NYSE:HIMS

$31.64 -0.52 (-1.60%)

Closing price 08/5/2026 03:59 PM Eastern

Extended Trading

$31.62 -0.02 (-0.06%)

As of 08/5/2026 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Labcorp NYSE:LH

$314.30 +1.96 (+0.63%)

Closing price 08/5/2026 03:59 PM Eastern

Extended Trading

$314.02 -0.28 (-0.09%)

As of 08/5/2026 07:34 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, DGX, LH, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, DGX, LH, and GH Earnings

Compare Dividends

Latest HIMS, DGX, LH, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, DGX, LH, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, DGX, LH, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Hims & Hers Health NYSE:HIMS

Labcorp NYSE:LH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools